BioCentury | Sep 1, 2017
Company News

Cancer Genetics acquires vivoPharm

...Cancer Genetics Inc. (NASDAQ:CGIX) acquired preclinical services company vivoPharm Pty. Ltd. (Kent Town, Australia) for about $12.4 million...
...announced. vivoPharm Pty. Ltd. , Bundoora, Australia Cancer Genetics Inc. (NASDAQ:CGIX), Rutherford, N.J. Business: Supply/Service Shannon Lehnbeuter Cancer Genetics Inc. vivoPharm Pty. Ltd....
BioCentury | May 11, 2015
Company News

vivoPharm, Protea Biosciences deal

...Protea will acquire cancer services company vivoPharm for $5.5 million in cash and $5.7 million in...
...newly issued convertible preferred stock. Protea said it will combine its mass spectrometry system with vivoPharm’s...
...in sales for 2014, and vivoPharm had A$5.6 million ($4.6 million) in the same period. vivoPharm...
Items per page:
1 - 2 of 2
BioCentury | Sep 1, 2017
Company News

Cancer Genetics acquires vivoPharm

...Cancer Genetics Inc. (NASDAQ:CGIX) acquired preclinical services company vivoPharm Pty. Ltd. (Kent Town, Australia) for about $12.4 million...
...announced. vivoPharm Pty. Ltd. , Bundoora, Australia Cancer Genetics Inc. (NASDAQ:CGIX), Rutherford, N.J. Business: Supply/Service Shannon Lehnbeuter Cancer Genetics Inc. vivoPharm Pty. Ltd....
BioCentury | May 11, 2015
Company News

vivoPharm, Protea Biosciences deal

...Protea will acquire cancer services company vivoPharm for $5.5 million in cash and $5.7 million in...
...newly issued convertible preferred stock. Protea said it will combine its mass spectrometry system with vivoPharm’s...
...in sales for 2014, and vivoPharm had A$5.6 million ($4.6 million) in the same period. vivoPharm...
Items per page:
1 - 2 of 2